Kazia Therapeutics (KZIA) Loans - Gross (2009 - 2025)

Kazia Therapeutics' (KZIA) quarterly Loans - Gross came in at $202128.1 in Q4 2025, up 249.81% on a QoQ basis from $57782.4 in Q2 2025.

Kazia Therapeutics (KZIA) Loans - Gross (2009 - 2025) Analysis & Trends

Kazia Therapeutics (KZIA) has 8 years of Loans - Gross data on file, last reported at $202128.1 in Q4 2025.

Quarterly Loans - Gross changed N/A year-over-year to $202128.1 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $202128.1 (changed N/A YoY) and the FY2025 annual result came in at $57782.4, changed N/A from the prior year.
Loans - Gross rose to $202128.1 in Q4 2025, from $57782.4 in the prior quarter.
In the past five years, Loans - Gross ranged from a high of $202128.1 in Q4 2025 to a low of $57782.4 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Loans - Gross (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Kazia Therapeutics	4.22 Bn	4.22 Bn	-	202,128.09

Download Data